openPR Logo
Press release

Cancer Biomarkers Market Rising at 11.45% CAGR to 2023: Top Key Players are Abbott Laboratories, Agendia Bv, Biocurex Inc, Biomerieux S.A, Biomoda Inc, Astellas Pharma Us Inc, Correlogic Systems Inc, Becton, Dickinson And Company

11-23-2018 11:07 AM CET | Health & Medicine

Press release from: Market Data Forecast

We Think Through Different Layers, We Work Across Different Verticals.

We Think Through Different Layers, We Work Across Different Verticals.

Cancer Biomarkers Market overview:
Biomarkers are chemical, physical or biological parameters which can be used to identify disease states. Oncology biomarkers recommends high speed, non invasive cancer diagnosis and deem to improve cancer detection and screening. Biomarker research is increasing high importance these days owing to its benefits such as accurate detection, easier diagnosis, and low chances of misdiagnosis during early cancer diagnosis. Comparison of cancer biomarkers at two different sites is very helpful for identifying metastatic tumours. Many different types of biomarkers have been characterized earlier and are in use in numerous cancer diagnostic testing procedures.

Request for Sample @ https://www.marketdataforecast.com/market-reports/cancer-biomarkers-market-2239/request-sample/

Key driving factors for the market are restructured drug delivery procedure, non invasive technology, augmented rates of survival. Boost in government and private funding for oncology also fuels the market development. Market is constrained by high cost of diagnosis, issues linked to reimbursement and some of the regulatory policies which hamper the market growth.

Cancer Biomarkers Market Forecast Report (2018-2023):
Global Cancer Biomarkers Market worth was USD 12.86 billion in 2018 and estimated to be growing at a CAGR of 11.45%, to reach USD 22.11 billion by 2023.

Browse Report Brief and TOC @ https://www.marketdataforecast.com/market-reports/cancer-biomarkers-market-2239/

Global cancer biomarkers Market Segmentation:
Global cancer biomarkers is segmented on the basis of disease into Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Other Cancers. Based on facilities market is divided into Sample Preparation, Assay development and Biomarkers validation and testing. On the base of application, market is bifurcated into Risk Assessment, Development of molecular diagnostics, Disease diagnosis, Drug discovery and Development and Drug formulation. By Type, the cancer biomarkers market is separated into Protein Biomarkers, Genetic biomarkers and other biomarkers. Based on profiling technologies, segmentation is between omics technologies, Imaging technologies, Immunoassays, Cytogenetics, Bioinformatics and IVD multivariate index assays. Omics technologies sector is further sub segmented into Genomics, Proteomics, Metabolomics, Transcriptomics and Pharmacogenomics.

Based on geography, the market is analysed under different regions namely, North America, Europe, Latin America, Asia-Pacific and Middle-East & Africa. The Asia-Pacific market is poised to record the maximum growth rate in the forecast period due to the supporting government funding for cancer biomarker research, increasing prevalence of cancer, rising demand for advanced healthcare facilities in developing economies such as India and China, growing number of clinical trials, and rising focus of international players in emerging markets.

Key Developments in the Market:
• January 2018: Roche and GE entered into a partnership to expand integrated digital diagnostics platform to improve oncology and critical care treatment. This partnership will relate advanced analytics to in-vivo data from GE’s medical imaging and monitoring equipment with in-vitro data from Roche’s biomarker, tissue pathology, genomics, and sequencing portfolio.
• January 2018: New biomarkers establish for colorectal cancer (MYO5B).

Buy now@ https://www.marketdataforecast.com/cart/buy-now/cancer-biomarkers-market-2239/

Major Players:
Some of the major companies in this cancer biomarkers market are
• Abbott Laboratories,
• Agendia Bv
• Biocurex Inc
• Biomerieux S.A.
• Biomoda Inc
• Astellas Pharma Us Inc
• Correlogic Systems Inc
• Beckman Coulter Inc
• Becton
• Dickinson And Company
• Clarient Inc
• Diadexus Inc
• Ambrilia Biopharma
• Affymetrix Inc and Aureon Laboratories Inc
• Shxchangyu

Customize Report@ https://www.marketdataforecast.com/market-reports/cancer-biomarkers-market-2239/customize-report/

About Us
Market Data Forecast is a determined working in the areas of market research, business intelligence and consulting. We have great experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.

For more information:
Abhishek Shukla
Sales Manager at Market Data Forecast
Email: abhishek@marketdataforecast.com
Tel: +1-888-702-9626
Website: www.marketdataforecast.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Biomarkers Market Rising at 11.45% CAGR to 2023: Top Key Players are Abbott Laboratories, Agendia Bv, Biocurex Inc, Biomerieux S.A, Biomoda Inc, Astellas Pharma Us Inc, Correlogic Systems Inc, Becton, Dickinson And Company here

News-ID: 1394804 • Views:

More Releases from Market Data Forecast

Middle East and Africa Steel Rebar Market Sees Explosive Growth Globally
Middle East and Africa Steel Rebar Market Sees Explosive Growth Globally
According to the latest research report published by Market Data Forecast, the middle east steel rebar market was worth US$ 8.59 billion in 2023 and is anticipated to reach a valuation of US$ 13.19 billion by 2029 and it is predicted to register a CAGR of 7.4% during the forecast period 2024-2029. the Middle East is driving strong demand for steel rebar, the backbone of reinforced concrete. This growth is fueled
Middle East and Africa Industrial Lubricants Market Share, Industry Analysis & Forecast Report 2024-2029.
Middle East and Africa Industrial Lubricants Market Share, Industry Analysis & F …
According to the latest research report published by Market Data Forecast, the middle east and africa industrial lubricants market was worth US$ 18.51 billion in 2023 and is anticipated to reach a valuation of US$ 22.62 billion by 2029 and it is predicted to register a CAGR of 3.4% during the forecast period 2024-2029. Industrial lubricants in the Middle East and Africa are specialized substances vital for reducing friction and wear
Steam Methane Reforming Market Share, Industry Analysis & Forecast Report 2024-2029.
Steam Methane Reforming Market Share, Industry Analysis & Forecast Report 2024-2 …
According to the latest research report published by Market Data Forecast, the global steam methane reforming market size was valued at USD 691.67 million in 2023 and is projected to reach USD 1004.13 million by 2029, growing at a CAGR of 6.41% during the forecast period 2024 to 2029. Steam reforming of methane mainly involves two reactions: the water gas shift reaction and the reforming reaction. In the latter case, natural
Telecom Tower Market is set for a Potential Growth
Telecom Tower Market is set for a Potential Growth
According to the latest research report published by Market Data Forecast, the global telecom tower market is predicted to reach USD 3.74 billion in 2024 and USD 7.07 billion by 2029, growing at a CAGR of 13.59% during the forecast period. Telecom towers are the backbone of any mobile telecommunications system. The telecom tower is a structure that houses a transceiver to maintain connection with thousands of mobile phones and the

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top